PharmaCyte Biotech, Inc. (PMCB) - Financial and Strategic SWOT Analysis Review

Market: Pharmaceuticals and Healthcare

United States, 25 pages report, published by GlobalData

Keywords : PharmaCyte Biotech, Inc., SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History, Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

Report ThumbnailOctober-2016

PharmaCyte Biotech, Inc. (PharmaCyte), formerly Nuvilex, Inc. is a clinical stage biotechnology company that develops and commercializes treatments for cancer and diabetes. The company develops Cell-in-a-Box cellulose-based live cell encapsulation technology. Its technology is used for the treatment of advanced and inoperable pancreatic cancer, and diabetes. PharmaCyte’s treatment for pancreatic cancer consists of the combination of live cells encapsulated using Cell-in-a-Box technology together with low doses of the anticancer prodrug ifosfamide. It conducts research in the areas of live cell encapsulation technology, pancreatic cancer, diabetes, cannabinoids and cancer, and breast cancer. PharmaCyte is headquartered in Laguna Hills, California, the US.

PharmaCyte Biotech, Inc. Key Recent Developments

Aug 02, 2016: Dr. Mark L. Rabe Presents PharmaCyte Biotech’s Ongoing Research at Cannabis Cancer Forum
Jul 05, 2016: PharmaCyte’s Research on Medical Uses of Cannabinoids Supported by Recent Scientific Article
May 03, 2016: PharmaCyte Biotech Appoints Former Johnson & Johnson Executive as Senior Business Development Advisor
Feb 24, 2016: PharmaCyte Biotech on Schedule for 2016 Cancer Clinical Trial in Pancreatic Cancer
Feb 08, 2016: Johnson & Johnson and Big Pharma Could Find a Diabetes "Cure" With PharmaCyte Biotech's Type 1 Diabetes Treatment

This comprehensive SWOT profile of PharmaCyte Biotech, Inc. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of PharmaCyte Biotech, Inc. including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
  • List of Figures
  • PharmaCyte Biotech, Inc., Performance Chart
  • PharmaCyte Biotech, Inc., Ratio Charts
  • List of Tables
  • PharmaCyte Biotech, Inc., Key Information
  • PharmaCyte Biotech, Inc., Key Ratios
  • PharmaCyte Biotech, Inc., Share Data
  • PharmaCyte Biotech, Inc., Major Products and Services
  • PharmaCyte Biotech, Inc., History
  • PharmaCyte Biotech, Inc., Key Employees
  • PharmaCyte Biotech, Inc., Key Employee Biographies
  • PharmaCyte Biotech, Inc., Key Operational Heads
  • PharmaCyte Biotech, Inc., Other Locations
  • PharmaCyte Biotech, Inc., Subsidiaries
  • PharmaCyte Biotech, Inc., Key Manufacturing facilities
  • PharmaCyte Biotech, Inc., Key Competitors
  • PharmaCyte Biotech, Inc., SWOT Analysis
  • PharmaCyte Biotech, Inc., Ratios based on current share price
  • PharmaCyte Biotech, Inc., Annual Ratios
  • PharmaCyte Biotech, Inc., Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
  • Table of Contents
  • Section 1 - About the Company
  • PharmaCyte Biotech, Inc. - Key Information
  • PharmaCyte Biotech, Inc. - Overview
  • PharmaCyte Biotech, Inc. - Key Employees
  • PharmaCyte Biotech, Inc. - Key Employee Biographies
  • PharmaCyte Biotech, Inc. - Key Operational Heads
  • PharmaCyte Biotech, Inc. - Major Products and Services
  • PharmaCyte Biotech, Inc. - History
  • PharmaCyte Biotech, Inc. - Company Statement
  • PharmaCyte Biotech, Inc. - Locations And Subsidiaries
  • PharmaCyte Biotech, Inc. - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
  • Section 2 - Company Analysis
  • PharmaCyte Biotech, Inc. - Business Description
  • PharmaCyte Biotech, Inc. - Corporate Strategy
  • PharmaCyte Biotech, Inc. - SWOT Analysis
  • SWOT Analysis - Overview
  • PharmaCyte Biotech, Inc. - Strengths
  • PharmaCyte Biotech, Inc. - Weaknesses
  • PharmaCyte Biotech, Inc. - Opportunities
  • PharmaCyte Biotech, Inc. - Threats
  • PharmaCyte Biotech, Inc. - Key Competitors
  • Section 3 - Company Financial Performance Charts
  • PharmaCyte Biotech, Inc. - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
  • Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About GlobalData
  • Contact Us
  • Disclaimer
  • Note*: Some sections may be missing if data is unavailable for the company

Please select a license type


Related Products

GlobalDataPharmaCyte Biotech, Inc. (PMCB) - Financial and Strategic SWOT Analysis ReviewProduct ThumbnailPharmaCyte Biotech, Inc. (PMCB) - Financial and Strategic SWOT Analysis Review, Company Report available for $300Product #: 46317
Global Markets Direct
GBI Research
PayPal Acceptance Mark
SSL Certificate
Copyright © 2017 Global Market Analyst. All Rights Reserved